Cargando…
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
BACKGROUND: Mutations in the EZH2 gene are recurrently found in patients with myeloid neoplasms and are associated with a poor prognosis. We aimed to characterize genetic and epigenetic alterations of EZH2 in 58 patients (51 with acute myeloid leukemia and 7 with myelodysplastic or myeloproliferativ...
Autores principales: | Stomper, Julia, Meier, Ruth, Ma, Tobias, Pfeifer, Dietmar, Ihorst, Gabriele, Blagitko-Dorfs, Nadja, Greve, Gabriele, Zimmer, Dennis, Platzbecker, Uwe, Hagemeijer, Anne, Schmitt-Gräff, Annette, Lübbert, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043064/ https://www.ncbi.nlm.nih.gov/pubmed/33845873 http://dx.doi.org/10.1186/s13148-021-01052-2 |
Ejemplares similares
-
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
por: Stomper, Julia, et al.
Publicado: (2021) -
Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat
por: Blagitko-Dorfs, Nadja, et al.
Publicado: (2013) -
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts
por: Greve, Gabriele, et al.
Publicado: (2023) -
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
por: Stomper, Julia, et al.
Publicado: (2021) -
Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells
por: Öz, Simin, et al.
Publicado: (2014)